Bicycle Therapeutics: Maybe Underwhelming, But I Don't Think They Should Be This Discounted

Company Overview - Bicycle Therapeutics (NASDAQ: BCYC) is a developmental biotech company focused on novel conjugated targeted therapies aimed at exploiting cell surface targets in cancer [1] Analyst Insights - Analysts, including those from Avisol Capital Partners, have been evaluating Bicycle Therapeutics over the past two years, indicating a growing interest in the company's potential within the biotech sector [1]